71,077 Shares in Phreesia, Inc. $PHR Bought by SG Americas Securities LLC

SG Americas Securities LLC purchased a new position in Phreesia, Inc. (NYSE:PHR) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 71,077 shares of the company’s stock, valued at approximately $1,203,000. SG Americas Securities LLC owned about 0.12% of Phreesia as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Federated Hermes Inc. bought a new stake in Phreesia in the third quarter worth $32,000. Asset Management One Co. Ltd. bought a new stake in shares of Phreesia during the third quarter worth $45,000. State of Alaska Department of Revenue bought a new stake in shares of Phreesia during the third quarter worth $83,000. Anchor Investment Management LLC bought a new stake in shares of Phreesia during the third quarter worth $118,000. Finally, Smartleaf Asset Management LLC lifted its position in shares of Phreesia by 129.0% during the third quarter. Smartleaf Asset Management LLC now owns 6,449 shares of the company’s stock worth $152,000 after purchasing an additional 3,633 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

PHR has been the subject of several research analyst reports. Canaccord Genuity Group decreased their target price on Phreesia from $33.00 to $22.00 and set a “buy” rating for the company in a research report on Tuesday, March 31st. BMO Capital Markets decreased their target price on Phreesia from $32.00 to $14.00 and set an “outperform” rating for the company in a research report on Tuesday, March 31st. Zacks Research downgraded Phreesia from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 6th. Mizuho decreased their target price on Phreesia from $22.00 to $19.00 and set an “outperform” rating for the company in a research report on Tuesday, March 24th. Finally, Royal Bank Of Canada initiated coverage on Phreesia in a research report on Friday, January 9th. They set a “moderate buy” rating and a $26.00 target price for the company. Twelve research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $22.00.

Phreesia Stock Performance

Shares of Phreesia stock opened at $9.07 on Wednesday. The firm has a market cap of $550.82 million, a P/E ratio of 302.17 and a beta of 0.86. The company has a current ratio of 1.53, a quick ratio of 2.44 and a debt-to-equity ratio of 0.41. Phreesia, Inc. has a 12 month low of $7.77 and a 12 month high of $32.76. The stock’s fifty day moving average price is $11.66 and its 200-day moving average price is $17.04.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, March 30th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.05). The firm had revenue of $127.07 million for the quarter, compared to analysts’ expectations of $126.75 million. Phreesia had a net margin of 0.48% and a return on equity of 3.23%. The business’s quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.11) EPS. On average, equities research analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Insider Transactions at Phreesia

In other news, CFO Balaji Gandhi sold 8,009 shares of the firm’s stock in a transaction on Thursday, January 8th. The stock was sold at an average price of $17.01, for a total transaction of $136,233.09. Following the transaction, the chief financial officer owned 156,231 shares in the company, valued at approximately $2,657,489.31. This trade represents a 4.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, General Counsel Allison C. Hoffman sold 6,585 shares of the firm’s stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.01, for a total value of $112,010.85. Following the transaction, the general counsel owned 174,762 shares in the company, valued at approximately $2,972,701.62. This represents a 3.63% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 70,358 shares of company stock worth $1,123,569. Corporate insiders own 5.50% of the company’s stock.

Phreesia Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.